Intensive therapeutic plasma exchange in life-threatening ANCA-associated vasculitis
- 10 May 2025
- journal article
- Published by Oxford University Press (OUP) in Rheumatology
- Vol. 64 (9) , 5193-5195
Abstract
No abstract availableThis publication has 11 references indexed in Scilit:
- Does plasma exchange have a role in ANCA-associated vasculitis? Viewpoint 2: plasma exchange may be useful under some circumstancesRheumatology, 2025
- Does plasma exchange have a role in ANCA-associated vasculitis? Viewpoint 1: plasma exchange should not be used indiscriminatelyRheumatology, 2025
- The effects of plasma exchange and glucocorticoids on early kidney function among patients with ANCA-associated vasculitis in the PEXIVAS trialKidney International, 2024
- Alveolar Hemorrhage in Antineutrophil Cytoplasmic Antibody–Associated Vasculitis: Results of an International Randomized Controlled Trial (PEXIVAS)American Journal of Respiratory and Critical Care Medicine, 2024
- KDIGO 2024 Clinical Practice Guideline for the Management of Antineutrophil Cytoplasmic Antibody (ANCA)–Associated VasculitisKidney International, 2024
- Challenge of diagnosing ANCA-associated vasculitis during COVID-19 pandemic: a missed ‘window of opportunity'Annals of the Rheumatic Diseases, 2023
- The effects of plasma exchange in patients with ANCA-associated vasculitis: an updated systematic review and meta-analysisBMJ, 2022
- Plasma Exchange and Glucocorticoids in Severe ANCA-Associated VasculitisNew England Journal of Medicine, 2020
- Alveolar haemorrhage in ANCA-associated vasculitis: Long-term outcome and mortality predictorsJournal of Autoimmunity, 2020
- Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special IssueJournal of Clinical Apheresis, 2019